Endometriosis Market Size, Share and Forecast 2018-2023

Posted by nabeel on December 22nd, 2020

Endometriosis is a painful disorder in which the layer of tissue that normally surfaces inside the uterus, starts growing outside the uterus. This mainly occurs on the fallopian tubes, ovaries, and tissue around the uterus; however, in exceptional cases it may occur in other parts of the body. The endometriosis leads to various physical symptoms such as severe menstrual cramps, nausea and vomiting, fatigue, diarrhea, constipation, long-term pelvic pain, and periods lasting over 7 days, among others. Moreover, the impending treatment of endometriosis market may lead to infertility, formation of ovarian cysts, inflammation, and scar tissue and adhesion development, among others. According to endometriosis.org, the disorder affects an approximately of one in 10 women during their reproductive years, estimating to around 176 million women in the world.

Get Free Sample Copy @

https://www.omrglobal.com/request-sample/endometriosis-market 

Increasing female population of the reproductive age and growing awareness rate of the disease are some of the factors significantly contributing towards the growth of the global endometriosis market. High investment made by the government in the R&D of endometriosis disorder, so as to introduce enhanced medical treatment is fueling the market growth. Moreover, growing prevalence of endometriosis across the globe is leading to the expansion of product portfolio by major market players in the endometriosis market. However, high cost of advanced therapeutic drugs, high investment required for the R&D of novel drugs, and time required for the diagnosing of the disease are some of the factors hampering the growth of the global endometriosis market.

CHAPTER 4. MARKET SEGMENTATION
4.1. GLOBAL ENDOMETRIOSIS MARKET, BY DRUG TYPE
4.1.1. GONADOTROPINS RELEASING HORMONE AGONISTS
4.1.2. NON-STEROIDAL ANTI-INFLAMMATORY DRUGS
4.1.3. PROGESTIN
4.1.4. ORAL CONTRACEPTIVE PILLS
4.2. GLOBAL ENDOMETRIOSIS MARKET, BY DIAGNOSIS TYPE
4.2.1. ULTRASOUND
4.2.2. PELVIC EXAM
4.2.3. LAPAROSCOPY
4.2.4. MAGNETIC RESONANCE IMAGING (MRI)
4.2.5. HYSTEROSCOPY
4.2.6. SONOHYSTEROGRAPHY
4.3. GLOBAL ENDOMETRIOSIS MARKET, BY TREATMENT TYPE
4.3.1. HORMONAL THERAPY
4.3.2. PAIN MANAGEMENT
4.4. GLOBAL ENDOMETRIOSIS MARKET BY DISTRIBUTION CHANNEL
4.4.1. HOSPITAL PHARMACIES
4.4.2. DRUG STORES
4.4.3. RETAIL PHARMACIES
4.4.4. MAIL ORDER PHARMACIES
4.4.5. E-COMMERCE

CHAPTER 5. COMPETITIVE LANDSCAPE
5.1. KEY COMPANY ANALYSIS
5.2. KEY STRATEGY ANALYSIS

CHAPTER 6. REGIONAL ANALYSIS
6.1. NORTH AMERICAN
6.1.1. UNITED STATES
6.1.2. CANADA
6.2. EUROPE
6.2.1. U.K
6.2.2. GERMANY
6.2.3. ITALY
6.2.4. SPAIN
6.2.5. FRANCE
6.2.6. ROE
6.3. ASIA PACIFIC
6.3.1. INDIA
6.3.2. CHINA
6.3.3. JAPAN
6.3.4. ROAPAC
6.4. REST OF THE WORLD

CHAPTER 7. COMPANY PROFILES
7.1. ABBOTT
7.2. ABBVIE INC.
7.3. ADDEX THERAPEUTICS
7.4. ALLERGAN
7.5. ASTELLAS PHARMA INC.
7.6. ASTRAZENECA
7.7. BAYER AG
7.8. DEBIOPHARM GROUP
7.9. ELEXOPHARM
7.10. EVESTRA, INC.
7.11. FORENDO PHARMA
7.12. IPSEN
7.13. KISSEI PHARMACEUTICAL CO., LTD.
7.14. MEDITRINA PHARMACEUTICALS
7.15. MYOVANT SCIENCES LTD.
7.16. NEUROCRINE BIOSCIENCES, INC.
7.17. OBSEVA SA
7.18. OGEDA S.A.
7.19. ORPHAGEN PHARMACEUTICALS, INC.
7.20. PFIZER, INC.
7.21. PHILOGEN
7.22. REPROS THERAPEUTICS INC.
7.23. SANOFI
7.24. TAKEDA PHARMACEUTICAL COMPANY LIMITED
7.25. TEVA PHARMACEUTICAL INDUSTRIES LTD.
7.26. VALIRX

For More Customized Data, Request for Report Customization @
https://www.omrglobal.com/report-customization/endometriosis-market 

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

Media Contact:

Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com 
Contact no: +91 780-304-0404